Ligand design by a combinatorial approach based on modeling and experiment: application to HLA-DR4

Area of Science:

• Computational chemistry and drug discovery
• Structural biology
• Immunology

Background:

• Combinatorial synthesis and screening accelerate drug discovery but explore limited chemical space.
• Structure-based computational design can focus libraries on promising chemical regions.
• Novel lead compounds are crucial for identifying new therapeutics.

Purpose of the Study:

• To apply structure-based computational design to create a focused combinatorial library for the class II MHC protein HLA-DR4.
• To synthesize and screen the computationally designed library.
• To validate the binding of designed ligands to HLA-DR4.

Main Methods:

• Utilized the Multiple Copy Simultaneous Search (MCSS) method for active site mapping and de novo structure-based design.
• Designed a focused combinatorial library targeting HLA-DR4.
• Synthesized and screened the library, employing experimental validation techniques.

Main Results:

• Successfully designed and synthesized a focused combinatorial library for HLA-DR4.
• Experimental evidence confirmed binding of library compounds to HLA-DR4.
• Cross-exclusion assays indicated binding modes similar to native peptides.

Conclusions:

• Structure-based computational design is effective for creating focused combinatorial libraries in drug discovery.
• The MCSS method successfully guided the design of HLA-DR4 ligands.
• This strategy enhances the efficiency of identifying novel lead compounds with potential therapeutic value.